Nigerians want death penalty for drug fakers; J&J faces federal probe;

> A Nigerian group has called on the National Assembly to pass a law calling for the death penalty for drug counterfeiters.  News

> Johnson & Johnson can now add a federal grand jury investigation to the fallout list from its Tylenol recall. Report

> Asthma inhalers stolen from GlaxoSmithKline are beginning to appear in U.S. pharmacies. Story

> Eisai plans to move production of its Alzheimer's drug Aricept to India, in the first such move by a Japanese pharma company. Article

> A five-year expansion project at CMO Ash Stevens in Detroit will boost production by 50 to 80 percent. Article

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.